Biosensors in North America

Key Highlights

• Biosensors are devices used to test the presence of biological material like microorganisms (such as bacteria, viruses, rickettsia, parasites, or fungi). They are frequently used in the healthcare sector to detect, recognize, and monitor a range of human disorders.
• The North American biosensors market recorded revenues of $12.66 billion in 2024, representing a compound annual growth rate (CAGR) of 7.3% between 2019 and 2024.
• The point of care (PoC) segment accounted for the market's largest proportion in 2024, with total revenues of $5.76 billion, equivalent to 45.5% of the market's overall value.
• The North American market growth is driven by the increasing household consumption expenditure on health leading to a rise in demand for preventive and diagnostic healthcare solutions, especially in chronic disease management and home healthcare.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biosensors market in North America
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biosensors market in North America
• Leading company profiles reveal details of key biosensors market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the North America biosensors market with five year forecasts

Reasons to Buy

• What was the size of the North America biosensors market by value in 2024?
• What will be the size of the North America biosensors market in 2029?
• What factors are affecting the strength of competition in the North America biosensors market?
• How has the market performed over the last five years?
• Who are the top competitors in North America's biosensors market?